While the interaction of the human immunodeficiency virus (HIV) envelope glycoprotein gp120 with CD4 and the chemokine receptors CXCR4 and CCR5 is clearly required to initiate HIV infection, it has now become evident that other cell membrane proteins, including the major adhesion molecule LFA-1 (CD11a/CD18) and its ligands ICAM-1, ICAM-2, and ICAM-3, are also involved in HIV infection (reviewed in reference 12). These molecules are expressed on cells that serve as hosts for the virus, as well as on the envelopes of HIV virions. Previous studies by Fortin et al. (6) and Rizutto and Sodroski (18) demonstrated that ICAM-1 incorporated into the envelopes of HIV virions increased the infectivity of the virus 2-to 10-fold. These results suggest that ICAM-1 molecules present on the surfaces of HIV virions are functional and capable of interacting with the LFA-1 receptor on the target cell surface and that this interaction facilitates virus binding to and entry into the cell.
While the interaction of the human immunodeficiency virus (HIV) envelope glycoprotein gp120 with CD4 and the chemokine receptors CXCR4 and CCR5 is clearly required to initiate HIV infection, it has now become evident that other cell membrane proteins, including the major adhesion molecule LFA-1 (CD11a/CD18) and its ligands ICAM-1, ICAM-2, and ICAM-3, are also involved in HIV infection (reviewed in reference 12). These molecules are expressed on cells that serve as hosts for the virus, as well as on the envelopes of HIV virions. Previous studies by Fortin et al. (6) and Rizutto and Sodroski (18) demonstrated that ICAM-1 incorporated into the envelopes of HIV virions increased the infectivity of the virus 2-to 10-fold. These results suggest that ICAM-1 molecules present on the surfaces of HIV virions are functional and capable of interacting with the LFA-1 receptor on the target cell surface and that this interaction facilitates virus binding to and entry into the cell.
LFA-1 and its ICAM ligands have also been shown to be necessary for syncytium formation in HIV-infected cultures and for efficient cell-to-cell transmission of the virus. Hildreth and Orentas (11) were the first to show that antibodies to LFA-1 inhibited syncytium formation induced by HIV. This finding was corroborated by other investigators who showed that syncytium formation in HIV-infected cultures was blocked by antibodies to the three ICAM ligands (2) . The LFA-1/ ICAM-1 interaction was also found to be important for conjugation between HIV-infected dendritic cells and CD4 ϩ T cells in the absence of any syncytium formation (20) . Blocking such interactions by monoclonal antibodies (MAbs) to LFA-1 or ICAM-1 reduced virus transfer from the dendritic cells to the T cells. Most recently, a dendritic-cell-specific C-type lectin, DC-SIGN, which binds ICAM-3 with high affinity, has been shown to play a role in promoting the capture of HIV type 1 (HIV-1) by dendritic cells and facilitating the transmission of the virus to CD4 ϩ T cells (8, 9) . LFA-1 is also known to affect HIV neutralization by virusspecific antibodies. Gomez and Hildreth (10) and Hioe et al. (13) demonstrated that HIV neutralization by HIV-positive plasma or by anti-gp120 MAbs was enhanced in the presence of MAbs to LFA-1. Hioe et al. (13) further showed that enhanced neutralization was observed when the anti-LFA-1 MAbs were present only during the initial 24 h of virus infection or were added 24 h postinfection. These results suggest that the anti-LFA-1 MAbs could act on different stages of HIV-1 infection, including the initial virus-cell interaction as well as the replication and spread of the virus from cell to cell.
Although previous studies have indicated that LFA-1 and its ICAM ligands are involved in multiple stages of HIV infection, little work has been done to determine to what extent the expression and activation state of LFA-1 on cells targeted by HIV affect virus infection and transmission. HIV-1 virions bearing ICAM-1 were more infectious than their ICAM-1-negative counterparts (6, 18) ; however, this observation is relevant only if the cells targeted by the virus express LFA-1 capable of binding ICAM-1. Moreover, the binding of LFA-1 to ICAM-1 requires activation of LFA-1: upon cellular stimulation by cross-linking of CD3, CD2, major histocompatibility complex class II molecules, or chemokine receptors, or by activation of protein kinase C with phorbol ester, LFA-1 undergoes a rapid and reversible conversion from a low-to a high-avidity state. Expression of the activated form of LFA-1 on T-cell lines was shown to render the cells more susceptible to infection by HIV (4) . Increased susceptibility to HIV was also observed with peripheral blood mononuclear cells and T-cell lines treated with antibodies that activate LFA-1 (7). Hence, LFA-1 expression and its activation state could significantly affect the susceptibility of cells to HIV infection and may influence the types of cells in which virus infection is established and to which it spreads.
In the present study we systematically examined the effects of LFA-1 expression and activation state on HIV infection and transmission by using human T-cell lines that differed one from another only by the expression and type of LFA-1 present on their cell surfaces. We used CD4 ϩ J␤2.7 T cells that lacked LFA-1 or had been transfected to express wild-type or mutant LFA-1. The generation and characterization of these cell lines were reported previously (15, 21, 22) . Briefly, the J␤2.7 cells were generated from Jurkat cells which had been treated with ethyl methanesulfonate and were selected for complete loss of cell surface LFA-1. The absence of LFA-1 expression was shown to be due to the absence of the LFA-1 ␣ chain (CD11a or ␣ L ). Thus, when the cells were transfected with cDNA of the wild-type ␣ subunit, cell surface expression of LFA-1 was restored; these cells were designated J␤2.7/LFA-1 wt. In addition, a J␤2.7 cell line expressing a constitutively active LFA-1 deletion mutant was generated (J␤2.7/LFA-1 ⌬). The LFA-1 deletion mutation was produced by deleting the conserved GFFKR sequence in the membrane-proximal cytoplasmic domain of the LFA-1 ␣ subunit. In contrast to the wild-type LFA-1, which requires cellular activation for high-affinity binding to ICAM-1, the GFFKR deletion mutant binds ICAM-1 constitutively and is locked in the highly adhesive state (15) . For this study, clones of J␤2.7/LFA-1 wt (clone 8) and J␤2.7/ LFA-1 ⌬ (clone 22) were used; their LFA-1 expression has been studied in detail and has previously been described (15) . For comparison, the J␤2.7 cells transfected with the vector alone were also produced (J␤2.7/mock); these cells expressed no LFA-1 on the surface. The expression levels of other membrane proteins, including CD4, CXCR4, ICAM-1, ICAM-2, and ICAM-3, on the three J␤2.7 transfectants were comparable (data not shown). These Jurkat-derived J␤2.7 cells do not express the CCR5 receptors. These cell lines were cultured in RPMI 1640 supplemented with 20% fetal bovine serum, Lglutamine, and 3 g of puromycin per ml.
Effect of LFA-1 expression on the initial events of HIV infection. With these J␤2.7 transfectants, the presence and activation state of LFA-1 on the surfaces of cells infected with HIV were studied to determine whether they had any effect on the initial events of virus infection, including virus attachment to the cells, entry into the cells, and integration. To address this question, we compared the amounts of virus that entered and initiated infection in the three J␤2.7 cell lines after 18 h of exposure to the virus. The level of HIV-1 DNA associated with each cell line was determined by PCR and Southern blotting as described previously (1) . Since J␤2.7 cells express CXCR4 but not CCR5 receptors, infection by a clade B X4R5-tropic HIV-1 isolate, SF33, and an X4-tropic HIV-1 laboratory strain, IIIB, was examined in the study. These viruses were grown in J␤2.7/ LFA-1 wt cells and expressed the ICAM ligands (data not shown). The same amount of cell-free virus supernatant (4.5 g of p24 for SF33 or 3.3 g of p24 for IIIB) was used to infect the three J␤2.7 cell lines (4 ϫ 10 6 cells/ml). After 18 h of infection, HIV-1 DNA was amplified from cell lysates (from an equivalent of 10 5 cells) using Gag-specific primers SK38 and SK39 with GeneAmplimer HIV-1 control reagents (PerkinElmer) to produce a 115-bp HIV-1 Gag fragment. PCR products were transferred to a nylon membrane, hybridized with internal probe SK19, and detected with a chemiluminescent digoxigenin system (Boehringer Mannheim). To normalize the amount of cellular DNA analyzed, ␤-actin DNA was also amplified from the same lysates.
The results show that more abundant HIV DNA was found in SF33-infected J␤2.7/LFA-1 wt than in J␤2.7/mock cells, while the amount of HIV DNA associated with SF33-infected J␤2.7/LFA-1 ⌬ cells was similar to that in J␤2.7/LFA-1 wt cells infected with the same virus (Fig. 1A) . In contrast, comparable amounts of ␤-actin DNA were detected in the three cell lines. This pattern was also observed with IIIB-infected J␤2.7 cells. To assess the results more precisely, we performed another experiment to measure the amount of HIV DNA in the IIIBinfected J␤2.7 cell lysate that was diluted 1:25, 1:50, and 1:100 (Fig. 1B) . Again, IIIB-infected J␤2.7/mock cells were found to contain the least virus DNA. However, it was now apparent that J␤2.7/LFA-1 ⌬ cells contained more HIV DNA than J␤2.7/LFA-1 wt cells. These results indicate that cells expressing LFA-1, either wild type or deletion mutant, were more readily infected with HIV than cells expressing no LFA-1, and the presence of constitutively active LFA-1 with high affinity for ICAM-1 appeared to further promote virus entry and infection. In consideration of the semiquantitative nature of the PCR and Southern blot techniques used in this study, we performed each experiment presented here at least twice, and indeed the same results were observed consistently in the repeated experiments; i.e., cells bearing constitutively active LFA-1 contained the most HIV DNA, while the LFA-1-negative cells contained the least.
To confirm that the enhanced virus infection seen in cells expressing LFA-1 was mediated by the interaction of LFA-1 on the cells with its ICAM ligands on the virus, HIV-1 bearing no ICAMs was prepared by transfecting an X4-tropic, infectious molecular clone of HIV-1 IIIB , R7-GFP, into human embryonic kidney 293T cells, which express no ICAMs and have been shown to produce a relatively high titer of cell-free virus (6) . After 18 h of infection with this ICAM-negative virus (0.5 g of p24 per 10 6 cells), similar levels of virus DNA were detected in the J␤2.7 cells expressing wild-type, mutant, or no LFA-1 (Fig. 2) . Thus, LFA-1-expressing J␤2.7 cells exhibited enhanced susceptibility to ICAM-bearing HIV but not to ICAMnegative virus. These results clearly demonstrate the specific contribution of the LFA-1/ICAM interaction in facilitating HIV infection.
HIV replication in J␤2.7 cells expressing wild-type, mutant, or no LFA-1. Next, we investigated the kinetics of p24 antigen production as a measure of the virus replication rate in the three J␤2.7 transfectants infected with SF33 or IIIB. For these experiments, each of the three J␤2.7 cell lines was incubated for 24 h at 37°C with the same amount of virus supernatant (1 g of p24 for SF33 or 0.8 g of p24 for IIIB per 10 6 cells), washed, and then cultured for up to 3 weeks. Cells were collected every 2 or 3 days and treated with 1% Triton X-100 (100 l/10 6 cells), and the amount of p24 in the cells was measured by a noncommercial enzyme-linked immunosorbent assay. As shown in Fig. 3 (top) , the level of p24 production in SF33-infected J␤2.7/mock cells was much lower than in J␤2.7/LFA-1 wt cells infected with the same virus. In J␤2.7/mock cells, the p24 concentration reached its peak on day 9 at 840 ng/ml, whereas in J␤2.7/LFA-1 wt cells, as much as 2,200 ng of p24 per ml was produced on day 9 postinfection. Overall, p24 production in J␤2.7/LFA-1 ⌬ cells was also lower than in J␤2.7/ LFA-1 wt cells, even though initially the p24 levels in these two cell lines were comparable. A more striking difference in the kinetics of p24 production was observed in IIIB-infected J␤2.7 cells (Fig. 3, bottom) . The p24 level reached its maximum at 1,400 ng/ml on day 9 in IIIB-infected J␤2.7/LFA-1 wt cells. In contrast, only 500 ng of p24 per ml was produced in J␤2.7/ LFA-1 ⌬ cells on day 9. In IIIB-infected J␤2.7/mock cells, both the rate and level of p24 production were also much lower: it took 16 days of infection to achieve a maximal p24 level of 800 ng/ml. These results, taken together with the data in Fig. 1 , indicate that the presence of LFA-1 on target cells, particularly the wild-type form, promotes HIV entry and replication in the cells. The constitutively active LFA-1 deletion mutant also enhances the initial events of HIV infection but seems to retard the subsequent process(es) (see below).
Effect of LFA-1 on virus spread in J␤2.7 cultures. The higher level of p24 found in HIV-infected J␤2.7/LFA-1 wt cells might be a reflection of a higher number of infected cells present in the J␤2.7/LFA-1 wt culture as a result of a more efficient spread of the virus from cell to cell in the culture. In contrast, virus spread to cells with no LFA-1 or with the LFA-1 deletion mutant might be less efficient, and thus, fewer infected cells would be present in the infected J␤2.7/mock and J␤2.7/ LFA-1 ⌬ cultures. To test this hypothesis, we quantitated the infected cells over time in the three J␤2.7 cultures following infection with SF33 or IIIB virus. Virus-infected cells were detected by intracellular anti-p24 antibody staining and were analyzed by flow cytometry. J␤2.7 cells were infected with SF33 or IIIB as described above for Fig. 3 and sampled periodically for staining with the fluorescent RD1-labeled anti-p24 MAb KC57 (Immunotech). Cells stained with an RD1-labeled isotype immunoglobulin control were used to establish background fluorescence. The results presented in Fig. 4 (top) demonstrate that the percentage of SF33-infected cells in the LFA-1-negative J␤2.7/mock culture increased slowly and attained a maximum of 19% on day 16. In contrast, in the J␤2.7/LFA-1 wt culture infected with the same virus, 27% of the cells were positive as early as day 9. In the J␤2.7/LFA-1 ⌬ culture, the number of infected cells rose rapidly during the first week but reached a plateau on day 9 at only 19%. A NOTESsimilar pattern was obtained when we compared the number of virus-infected cells in the three J␤2.7 cultures exposed to IIIB (Fig. 4, bottom) . For controls, uninfected J␤2.7 cells were stained with RD1-labeled KC57, and Ͻ0.7% positive cells were detected in each experiment (data not shown). These data clearly indicate that the number of infected cells increased more rapidly and reached a higher level in the J␤2.7/LFA-1 wt culture than in the J␤2.7/mock or J␤2.7/LFA-1 ⌬ cultures infected with the same virus. We also observed that the mean fluorescence intensity of the infected cells, while changing over time, was not significantly different among the three J␤2.7 cultures (data not shown), indicating that the amounts of p24 produced per cell were similar whether the cells expressed wild-type, mutant, or no LFA-1. These findings are consistent with the general pattern of p24 production seen in Fig. 3 and support the idea that the rate of virus spread in cells expressing wild-type LFA-1 is substantially greater than in the cells with the LFA-1 deletion mutant or with no LFA-1. It should be noted, however, that the different numbers of infected cells observed in Fig. 4 could reflect not only distinct rates of virus spread in the three cell lines but also the number of cells initially infected upon exposure to the virus (Fig. 1) . To measure more specifically the efficiency of virus spread in the infected J␤2.7 cultures, we performed experiments in which uninfected J␤2.7/LFA-1 wt, J␤2.7/LFA-1 ⌬, or J␤2.7/mock cells were each inoculated with a fixed number of SF33-infected J␤2.7/LFA-1 wt cells, so that 7% of infected J␤2.7/ LFA-1 wt cells were present initially in each of the mixed cultures (i.e., the ratio of infected to uninfected cells at the beginning of the culture was 7 to 100). We then compared the increase in the number of infected cells in each culture as the virus spread from SF33-infected J␤2.7/LFA-1 wt cells to the uninfected J␤2.7 cells with either wild-type, deletion mutant, or no LFA-1. The results show that the SF33 virus spread to J␤2.7/LFA-1 wt cells more readily than to either J␤2.7/mock or J␤2.7/LFA-1 ⌬ cells (Fig. 5) . Notably, the levels of virus transmission to J␤2.7/LFA-1 ⌬ and to J␤2.7/mock cells were similar, indicating that the LFA-1 deletion mutant, in contrast to the wild-type LFA-1, did not facilitate HIV spread in the J␤2.7 cultures, even though this constitutively active LFA-1 enhanced the initial infection by cell-free virus.
This study provides direct evidence that adhesion molecule LFA-1 expressed on the surfaces of cells targeted by HIV plays a significant role in promoting the initial stages of HIV infection. Thus, cells expressing LFA-1 are more prone to HIV infection than cells without LFA-1. The results complement previous findings which showed that the presence of ICAM-1 on the envelopes of HIV virions rendered the virus more infectious. Taken together, these studies support the hypothesis that LFA-1 on the target cells interacts with the ICAM ligands on the HIV virion; such an interaction facilitates virus binding to the cells and enhances the rate of virus entry and infection, presumably by helping to overcome the repulsive forces present between the negatively charged gp120 on the virion surface and the negatively charged cell membrane (3). In agreement with this notion, we observed that HIV infection was increased even more when the target cells expressed the mutant form of LFA-1 that constitutively retains a high adhesiveness for its ICAM ligands. Similar results were reported previously with a different human T-cell line (HPB-ALL) that was chemically mutated to express the constitutively active form of LFA-1 (4) and with peripheral blood mononuclear cells or T-cell lines treated with anti-LFA-1 antibodies that activate LFA-1 and convert it to a high adhesive form (7). Hence, a high-affinity LFA-1/ICAM-1 interaction is indeed beneficial for HIV's initial attachment to and entry into the target cells.
In contrast to the requirement for virus-cell attachment, we demonstrated here for the first time that to promote efficient cell-to-cell spread of HIV, the presence of activated and highly avid LFA-1 on the cell surface is not sufficient; rather, properly functional LFA-1 that can regulate its adhesiveness is required. We observed that the presence of the constitutively active LFA-1 deletion mutant on target cells did not promote virus replication and spread as seen with wild-type LFA-1, even though this LFA-1 deletion mutant helped establish the initial virus infection. It should also be noted that the cells expressing the LFA-1 deletion mutant tend to grow in tight clusters with most cells in close contact with neighboring cells, but virus spread was not accelerated in these cells. Although the reason for this phenomenon is not fully understood, these findings suggest at least three possible explanations. First, LFA-1 expression on HIV-infected cultures promotes syncytium formation (11) , and in the cells with constitutively active LFA-1, rapid syncytium formation and death of the fused cells may cause the virus production to drop off faster. Second, the high affinity between the virus and the constitutively active LFA-1 on the cells may hinder the cell-to-cell transfer of progeny virus. Previous studies by Weber et al. (21) revealed that J␤2.7/ LFA-1 ⌬ cells could not modulate cell-cell adhesiveness and failed to undergo transendothelial migration in response to chemokines. Similarly, virus particles produced in cells with the LFA-1 deletion mutant may adhere too tightly to the host cells and may not spread to other cells in the culture efficiently. In support of this idea, we observed, using the MAb-mediated virus capture assay, that virions produced in J␤2.7/LFA-1 ⌬ cells incorporated into their envelopes a high level of LFA-1, while virions from J␤2.7/LFA-1 wt cells acquired much fewer LFA-1 molecules (data not shown). Although it remains unclear whether the LFA-1 deletion molecules acquired by the HIV virions from the J␤2.7/LFA-1 ⌬ cells retained their highly adhesive state, the presence of such highly avid LFA-1 could potentially prevent the budding and detachment of virus progeny from the host cells. Third, the deletion in the cytoplasmic domain of the ␣ chain of the LFA-1 deletion mutant may affect the intracellular signaling and cytoskeleton rearrangement involved in the HIV maturation and/or budding process (14, 16, 17, 19) . As a result, fewer mature virions may be produced in LFA-1 deletion mutant-expressing cells than in the cells expressing wild-type LFA-1. Overall, the data from this study clearly show that the expression of functional LFA-1 with wellregulated adhesiveness on cells targeted by HIV significantly promotes HIV infection and transmission.
LFA-1 is expressed in vivo on various types of leukocytes, including lymphocytes, monocytes, and dendritic cells, that can be infected by HIV. In response to antigens, chemokines, and other inflammatory stimuli, LFA-1 on these cells becomes activated and capable of binding its ICAM ligands with high affinity. Our findings suggest that these stimulated cells would be more susceptible to HIV and could be the preferred targets for the virus. Thus, the presence of such cells in the mucosa at the site of HIV entry, for example, may allow the virus to more readily establish the initial infection. Subsequently, as indicated by this and other studies (11, 13, 20) , virus spread from infected cells to uninfected cells is also enhanced by the presence of LFA-1 on the cell surface. Furthermore, LFA-1 expression may have a greater impact on HIV infectivity when gp120 density on the virus is low, either due to shedding or because those gp120 molecules are concealed by antibodies. A number of studies have shown previously that LFA-1/ICAM-1 interaction between the virus and target cells reduces the effectiveness of anti-HIV antibodies in neutralizing the virus (5, 10, 13) . Therefore, LFA-1 and other adhesion molecules present on the cell surface and on the HIV virions are important determinants in HIV pathogenesis, affecting virus infectivity and transmission as well as virus neutralization by antibodies.
